勘误：阿尔茨海默病血液生物标志物与运动性认知风险综合征认知之间的关联：一项使用血浆Aβ42和总tau的初步研究。
Corrigendum: Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau.
作者信息
Chen Pei-Hao, Lin Sang-I, Liao Ying-Yi, Hsu Wei-Ling, Cheng Fang-Yu
机构信息
Department of Neurology, MacKay Memorial Hospital, Taipei, Taiwan.
Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
出版信息
Front Aging Neurosci. 2023 Jan 5;14:1125201. doi: 10.3389/fnagi.2022.1125201. eCollection 2022.
Abstract
[This corrects the article DOI: 10.3389/fnagi.2022.981632.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fnagi.2022.981632。]
相似文献
1
Corrigendum: Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau.勘误：阿尔茨海默病血液生物标志物与运动性认知风险综合征认知之间的关联：一项使用血浆Aβ42和总tau的初步研究。
Front Aging Neurosci. 2023 Jan 5;14:1125201. doi: 10.3389/fnagi.2022.1125201. eCollection 2022.
2
Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau.阿尔茨海默病血液生物标志物与运动性认知风险综合征认知功能之间的关联：一项使用血浆Aβ42和总tau的初步研究。
Front Aging Neurosci. 2022 Oct 4;14:981632. doi: 10.3389/fnagi.2022.981632. eCollection 2022.
3
PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.PTI-125 降低阿尔茨海默病患者的生物标志物。
J Prev Alzheimers Dis. 2020;7(4):256-264. doi: 10.14283/jpad.2020.6.
4
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用：系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.
5
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系：一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
6
Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.老年人血浆 p-tau231、p-tau181、PET 生物标志物与认知变化。
Ann Neurol. 2022 Apr;91(4):548-560. doi: 10.1002/ana.26308. Epub 2022 Feb 18.
7
Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levels.胰岛素抵抗、认知与阿尔茨海默病生物标志物：脑脊液β淀粉样蛋白42（CSF Aβ42）调节胰岛素抵抗与脑脊液总tau蛋白（CSF tau）水平升高之间关联的证据。
Neurobiol Aging. 2022 Jun;114:38-48. doi: 10.1016/j.neurobiolaging.2022.03.004. Epub 2022 Mar 11.
8
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.阿尔茨海默病风险加权多基因风险评分预测临床前阿尔茨海默病认知下降率的效用：一项前瞻性纵向研究。
J Alzheimers Dis. 2018;66(3):1193-1211. doi: 10.3233/JAD-180713.
9
Cognitive Dispersion Is Not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Results from the European Prevention of Alzheimer's Dementia (EPAD) v500.0 Cohort.认知离散与阿尔茨海默病的脑脊液生物标志物无关：来自欧洲预防阿尔茨海默病痴呆（EPAD）v500.0队列的结果。
J Alzheimers Dis. 2020;78(1):185-194. doi: 10.3233/JAD-200514.
10
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects.血浆标志物可预测非痴呆患者的淀粉样蛋白、tau 蛋白、萎缩和认知变化。
Brain. 2021 Oct 22;144(9):2826-2836. doi: 10.1093/brain/awab163.
引用本文的文献
1
Distinct Patterns of Brain Atrophy in Amnestic Mild Cognitive Impairment and Motoric Cognitive Risk Syndromes.遗忘型轻度认知障碍和运动认知风险综合征中不同的脑萎缩模式。
Neurodegener Dis. 2024;24(3-4):117-128. doi: 10.1159/000540512. Epub 2024 Aug 5.
Zotero 插件